For the period ended September 30, 2021, we had a net loss of U.S.$7,393 which consisted of formation and operating costs.
For the Period from February 11, 2021 (Inception) through December 31, 2021, we had a net loss of U.S.$11,080, which consisted of formation and operating costs.
Liquidity and Capital Resources
Prior to the consummation of the LIVB IPO, the Company’s only source of liquidity was the receipt of U.S.$25,000 from the sale of the founder shares and from the availability of up to U.S.$300,000 in loans from the Sponsor under an unsecured promissory note. As of September 30, 2022, we had borrowed U.S.$207,500 under the promissory note.
On February 10, 2022, we consummated our initial public offering of 10,000,000 Units, generating gross proceeds of U.S.$100,000,000. Simultaneously with the closing of the LIVB IPO, we consummated the sale of 5,500,000 private placement warrants at a price of U.S.$1.00 per private placement warrant in a private placement to the Sponsor, generating gross proceeds of U.S.$5,500,000. On February 15, 2022, the underwriters partially exercised their over-allotment option, resulting in an additional 1,450,000 LIVB Units issued for an additional amount of U.S.$14,500,000.
Following the LIVB IPO, the partial exercise of the over-allotment option, and the private placement, a total of U.S.$116,790,000 was placed in the Trust Account, after giving effect to the incurrence of U.S.$3,888,278 of transaction costs in the LIVB IPO and partial exercise of the over-allotment option, consisting of U.S.$2,290,000 of underwriting fees, and U.S.$1,598,278 of other offering costs.
For the nine months ended September 30, 2022, cash used in operating activities was U.S.$526,005. Our net loss of U.S.$1,965,041 was affected by interest earned on marketable securities held in the Trust Account of U.S.$703,883 and change in fair value of over-allotment option of U.S.$1,862. Changes in operating assets and liabilities provided U.S.$2,144,781 of cash for operating activities.
For the period from February 11, 2021 (inception) through September 30, 2021, cash used in operating activities was U.S.$0. For the period from February 11, 2021 (inception) through December 31, 2021, cash used in operating activities was U.S.$0.
As of September 30, 2022, we had marketable securities held in the Trust Account of U.S.$117,493,883 (including approximately U.S.$703,883 of interest income and unrealized gains) consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our business combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2022, we had cash of U.S.$3,998. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we would repay such loaned amounts.
212